ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Transcat Reports Second Quarter Adjusted EBITDA Increase of 35.5% to $7.1 Million on Strong Revenue Growth and Gross Margin Expansion

November 2, 2021 GMT

ROCHESTER, N.Y.--(BUSINESS WIRE)--Nov 2, 2021--

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its second quarter ended September 25, 2021 (the “second quarter”) of fiscal year 2022, which ends March 26, 2022 (“fiscal 2022”). Results include the previously reported acquisitions of BioTek Services, Inc. (“BioTek”) effective December 16, 2020, Upstate Metrology (“Upstate”) effective April 29, 2021 and Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management), (“NEXA”) effective August 31, 2021.

ADVERTISEMENT

“Our excellent second quarter results were driven by broad-based revenue strength and solid operational execution across both of our operating segments.” commented Lee D. Rudow, President and CEO. “Our Service segment revenue grew 20.3% and gross margin increased 70 basis points to a second quarter record of 32.9%. We reported 14.0% organic revenue growth as demand in our highly regulated end markets, including life sciences, remained strong. We are pleased with the continued expansion of our gross margin, which was largely driven by operating leverage on our fixed costs from organic growth.”

“Our Distribution segment revenue grew 22.2% on improved demand and an easier comparison against a prior-year period that was significantly impacted by the COVID-19 pandemic. Importantly, this segment has fully recovered from last year’s lows and is now exceeding pre-pandemic levels as revenue was up double-digits when compared to the second quarter of fiscal year 2020. Overall, our Service segment performance drove second quarter consolidated adjusted EBITDA of $7.1 million, an increase of $1.9 million or 35.5% from the prior year.”

Mr. Rudow added, “We are excited with the early progress made on our recent acquisition of NEXA Enterprise Asset Management. NEXA expands our reach into the attractive market for asset management services and its unique capabilities around managing cost, efficiency and the reliability components of life science companies’ instrumentation programs is a natural complement to our core calibration offerings. We are confident this enhances our overall value proposition to current and future customers and the NEXA and Transcat teams have already worked together to identify several synergistic growth opportunities.”

ADVERTISEMENT

Second Quarter Fiscal 2022 Review

(Results are compared with the second quarter of the fiscal year ended March 27, 2021 (“fiscal 2021”))

 

($ in thousands)

 

 

 

 

Change

FY22 Q2

 

FY21 Q2

 

$'s

 

%

Service Revenue

$

29,544

 

$

24,554

 

$

4,990

 

20.3%

Distribution Sales

 

20,843

 

 

17,053

 

 

3,790

 

22.2%

Revenue

$

50,387

 

$

41,607

 

$

8,780

 

21.1%

Gross Profit

$

14,611

 

$

11,494

 

$

3,117

 

27.1%

Gross Margin

 

29.0%

 

 

27.6%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

$

3,578

 

$

3,078

 

$

500

 

16.2%

Operating Margin

 

7.1%

 

 

7.4%

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

$

3,015

 

$

2,024

 

$

991

 

49.0%

Net Margin

 

6.0%

 

 

4.9%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

7,079

 

$

5,223

 

$

1,856

 

35.5%

Adjusted EBITDA* Margin

 

14.0%

 

 

12.6%

 

 

 

 

*See Note 1 on page 4 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Consolidated revenue was $50.4 million, an increase of 21.1%. Consolidated gross profit was $14.6 million, an increase of $3.1 million, or 27.1%, and gross margin expanded 140 basis points to 29.0% due to strong operational performance in both the Service and Distribution segments. Operating expenses increased $2.6 million, or 31.1%, driven by incremental expenses from acquired businesses, investments in technology and $0.8 million in one-time transaction expenses related to the NEXA acquisition that closed within the quarter. Adjusted EBITDA was $7.1 million and increased by 35.5%. Net income per diluted share increased to $0.40 from $0.27.

Service segment delivers strong second quarter results

 

Represents the accredited calibration, repair, inspection and laboratory instrument services business

 

(59% of total revenue for the second quarter of fiscal 2022).

 

($ in thousands)

 

 

 

 

Change

FY22 Q2

 

FY21 Q2

 

$'s

 

%

Service Segment Revenue

$

29,544

 

$

24,554

 

$

4,990

 

20.3%

Gross Profit

$

9,712

 

$

7,900

 

$

1,812

 

22.9%

Gross Margin

 

32.9%

 

 

32.2%

 

 

 

 

 

 

 

 

 

 

 

Operating Income

$

2,647

 

$

2,977

 

$

(330)

 

(11.1%)

Operating Margin

 

9.0%

 

 

12.1%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

5,460

 

$

4,475

 

$

985

 

22.0%

Adjusted EBITDA* Margin

 

18.5%

 

 

18.2%

 

 

 

 

* See Note 1 on page 4 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Service segment revenue increased 20.3% to $29.5 million and included $1.6 million of incremental revenue from acquisitions. Organic revenue growth was 14.0% and was driven by improvement in end market conditions, continued market share gains and an easier comparison over the prior-year quarter, which was impacted by the COVID-19 pandemic.

The segment gross margin increased by 70 basis points due continued strong technician productivity and operating leverage on fixed costs.

Distribution segment revenue and margins showed strong increases

 

Represents the sale and rental of new and used professional grade handheld test, measurement and control instrumentation (41% of total revenue for the second quarter of fiscal 2022).

 

($ in thousands)

 

 

 

 

Change

FY22 Q2

 

FY21 Q2

 

$'s

 

%

Distribution Segment Sales

$

20,843

 

$

17,053

 

$

3,790

 

22.2%

Gross Profit

$

4,899

 

$

3,594

 

$

1,305

 

36.3%

Gross Margin

 

23.5%

 

 

21.1%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

$

931

 

$

101

 

$

830

 

821.8%

Operating Margin

 

4.5%

 

 

0.6%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

1,619

 

$

748

 

$

871

 

116.4%

Adjusted EBITDA* Margin

 

7.8%

 

 

4.4%

 

 

 

 

* See Note 1 on page 4 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Distribution sales increased 22.2% on improved market conditions and an easier comparison to the prior year period, which was impacted by the COVID-19 pandemic. Distribution segment gross margin increased 240 basis points on a favorable mix of products sold.

Six Month Review(Results are compared with the first six months of fiscal 2021)

Total revenue was $98.2 million, an increase of 21.9%. Consolidated gross profit was up $7.2 million, or 34.6%, and gross margin expanded to 28.7% or 270 basis points. Consolidated operating expenses increased $4.0 million, or 23.7%, driven by incremental expenses from acquired businesses, investments in technology and $0.8 million in one-time transaction expenses related to the NEXA acquisition that closed in the second quarter. As a result, consolidated operating income was $7.3 million compared with $4.0 million in last fiscal year’s period.

Net income was $6.7 million, or $0.88 per diluted share, compared with $2.8 million, or $0.38 per diluted share. Adjusted EBITDA was $13.2 million, an increase of 51.4%. See Note 1 on page 4 for a description of this non-GAAP financial measure and page 10 for the Adjusted EBITDA Reconciliation table.

Balance Sheet Highlights

At September 25, 2021, the Company had $46.6 million available for borrowing under its secured revolving credit facility. Total debt of $43.1 million was up $23.5 million from fiscal 2021 year-end. The Company’s leverage ratio, as defined in the credit agreement, was 1.54 at September 25, 2021, compared with 0.94 at March 27, 2021.

Outlook

Mr. Rudow concluded, “The second quarter results were excellent and we are appreciative of the hard work and solid execution from our teams in both our Service and Distribution segments. We have a strong balance sheet, sustainable Service segment gross margins and an active M&A pipeline. We are confident that the strength of our unique and enhanced value proposition and our new customer pipeline positions us well for continued strong organic growth.

“For the third quarter of fiscal 2022, we expect Service total revenue growth to be similar to what we achieved in the second quarter, with roughly half of the growth to come organically and the other half coming from acquisition. We expect Service gross margin to expand over the prior year third quarter, similar to the level of year-over-year expansion we just achieved in the second quarter. Distribution revenue is expected to grow in the low teens in the third quarter on improved order trends and a prior-year comparison that includes lower levels of demand due to the COVID-19 pandemic.”

Transcat revised its fiscal year 2022 income tax rate to a range between 14% and 15% from the previous estimated range of 16% to 18%. This estimate includes Federal, various state, Canadian and Irish income taxes and reflects the discrete tax benefit associated with share-based payment and stock option activity.

Webcast and Conference Call

Transcat will host a conference call and webcast on Wednesday, November 3, 2021 at 11:00 a.m. ET. Management will review the financial and operating results for the second quarter, as well as the Company’s strategy and outlook. A question and answer session will follow the formal discussion. The review will be accompanied by a slide presentation, which will be available at www.transcat.com/investor-relations. The conference call can be accessed by calling (201) 689-8471. Alternatively, the webcast can be monitored at www.transcat.com/investor-relations.

A telephonic replay will be available from 2:00 p.m. ET on the day of the call through Wednesday, November 10, 2021. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13724485, access the webcast replay at www.transcat.com/investor-relations, where a transcript will be posted once available.

NOTE 1 – Non-GAAP Financial Measures

In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, restructuring expense, non-cash loss on sale of building and acquisition related transaction expenses), which is a non-GAAP measure. The Company’s management believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the performance of its core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense and other items, which is not always commensurate with the reporting period in which it is included. As such, the Company uses Adjusted EBITDA as a measure of performance when evaluating its business segments and as a basis for planning and forecasting. Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, rather in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. See the attached Adjusted EBITDA Reconciliation table below.

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses; as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada and Ireland, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found at: Transcat.com.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions. Forward-looking statements are identified by words such as “expects,” “estimates,” “projects,” “anticipates,” “believes,” “could,” “plans,” “aims” and other similar words. All statements addressing operating performance, events or developments that Transcat expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, the Company’s response to the coronavirus (“COVID-19”) pandemic, the commercialization of software projects, sales operations, capital expenditures, cash flows, operating income, growth strategy, segment growth, potential acquisitions, integration of acquired businesses, market position, customer preferences, outlook and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties include those more fully described in Transcat’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements, which speak only as of the date they are made. Except as required by law, the Company disclaims any obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this news release, whether as the result of new information, future events or otherwise.

FINANCIAL TABLES FOLLOW.

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

 

(Unaudited)

(Unaudited)

Second Quarter Ended

 

Six Months Ended

September 25,

 

September 26,

 

September 25,

 

September 26,

2021

 

2020

 

2021

 

2020

Service Revenue

$

29,544

$

24,554

$

57,101

$

47,521

Distribution Sales

 

20,843

 

17,053

 

41,076

 

32,990

Total Revenue

 

50,387

 

41,607

 

98,177

 

80,511

 

Cost of Service Revenue

 

19,832

 

16,654

 

38,637

 

33,552

Cost of Distribution Sales

 

15,944

 

13,459

 

31,409

 

26,056

Total Cost of Revenue

 

35,776

 

30,113

 

70,046

 

59,608

 

Gross Profit

 

14,611

 

11,494

 

28,131

 

20,903

 

Selling, Marketing and Warehouse Expenses

 

4,974

 

4,291

 

9,971

 

8,365

General and Administrative Expenses

 

6,059

 

4,125

 

10,893

 

8,496

Total Operating Expenses

 

11,033

 

8,416

 

20,864

 

16,861

 

Operating Income

 

3,578

 

3,078

 

7,267

 

4,042

 

Interest and Other Expense, net

 

250

 

317

 

445

 

560

 

Income Before Income Taxes

 

3,328

 

2,761

 

6,822

 

3,482

Provision for Income Taxes

 

313

 

737

 

119

 

660

 

Net Income

$

3,015

$

2,024

$

6,703

$

2,822

 

Basic Earnings Per Share

$

0.40

$

0.27

$

0.90

$

0.38

Average Shares Outstanding

 

7,482

 

7,417

 

7,473

 

7,405

 

Diluted Earnings Per Share

$

0.40

$

0.27

$

0.88

$

0.38

Average Shares Outstanding

 

7,595

 

7,549

 

7,578

 

7,525

TRANSCAT, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share and Per Share Amounts)

 
 

(Unaudited)

 

(Audited)

 

September 25,

 

March 27,

 

2021

 

2021

ASSETS

  

Current Assets:

  
Cash 

$

2,551

 

 

$

560

 

Accounts Receivable, less allowance for doubtful accounts of $698  
and $526 as of September 25, 2021 and March 27, 2021, respectively 

 

36,464

 

 

 

33,950

 

Other Receivables 

 

448

 

 

 

428

 

Inventory, net 

 

10,205

 

 

 

11,636

 

Prepaid Expenses and Other Current Assets 

 

4,105

 

 

 

2,354

 

Total Current Assets 

 

53,773

 

 

 

48,928

 

Property and Equipment, net

 

 

23,034

 

 

 

22,203

 

Goodwill

 

 

59,441

 

 

 

43,272

 

Intangible Assets, net

 

 

12,753

 

 

 

7,513

 

Right To Use Asset, net

 

 

8,393

 

 

 

9,392

 

Other Assets

 

 

919

 

 

 

808

 

Total Assets 

$

158,313

 

 

$

132,116

 

   

LIABILITIES AND SHAREHOLDERS' EQUITY

  

Current Liabilities:

  
Accounts Payable 

$

10,983

 

 

$

12,276

 

Accrued Compensation and Other Liabilities 

 

8,455

 

 

 

10,417

 

Income Taxes Payable 

 

-

 

 

 

382

 

Current Portion of Long-Term Debt 

 

2,134

 

 

 

2,067

 

Total Current Liabilities 

 

21,572

 

 

 

25,142

 

Long-Term Debt

 

 

40,917

 

 

 

17,494

 

Deferred Tax Liabilities

 

 

4,914

 

 

 

3,201

 

Lease Liabilities

 

 

6,705

 

 

 

7,958

 

Other Liabilities

 

 

3,461

 

 

 

3,243

 

Total Liabilities 

 

77,569

 

 

 

57,038

 

   

Shareholders' Equity:

  
Common Stock, par value $0.50 per share, 30,000,000 shares authorized;  
7,518,159 and 7,458,251 shares issued and outstanding  
as of September 25, 2021 and March 27, 2021, respectively 

 

3,759

 

 

 

3,729

 

Capital in Excess of Par Value 

 

22,713

 

 

 

19,287

 

Accumulated Other Comprehensive Loss 

 

(502

)

 

 

(451

)

Retained Earnings 

 

54,774

 

 

 

52,513

 

Total Shareholders' Equity 

 

80,744

 

 

 

75,078

 

Total Liabilities and Shareholders' Equity 

$

158,313

 

 

$

132,116

 

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

 
 

(Unaudited)

 

For the Six Months Ended

 

September 25,

 

September 26,

 

2021

 

2020

Cash Flows from Operating Activities:

 
Net Income 

$

6,703

 

$

2,822

 

Adjustments to Reconcile Net Income to Net Cash Provided 

 

by Operating Activities: 
Loss on Disposal of Property and Equipment 

 

84

 

 

68

 

Deferred Income Taxes 

 

7

 

 

47

 

Depreciation and Amortization 

 

4,131

 

 

3,736

 

Provision for Accounts Receivable and Inventory Reserves 

 

499

 

 

523

 

Stock-Based Compensation Expense 

 

1,057

 

 

678

 

Changes in Assets and Liabilities: 
Accounts Receivable and Other Receivables 

 

(374

)

 

3,543

 

Inventory 

 

1,739

 

 

623

 

Prepaid Expenses and Other Assets 

 

(1,847

)

 

(625

)

Accounts Payable 

 

(1,293

)

 

(892

)

Accrued Compensation and Other Liabilities 

 

(2,812

)

 

1,626

 

Income Taxes Payable 

 

(392

)

 

327

 

Net Cash Provided by Operating Activities 

 

7,502

 

 

12,476

 

  

Cash Flows from Investing Activities:

 
Purchase of Property and Equipment 

 

(3,770

)

 

(3,116

)

Business Acquisitions, net of cash acquired 

 

(20,910

)

 

-

 

Net Cash Used in Investing Activities 

 

(24,680

)

 

 

(3,116

)

  

Cash Flows from Financing Activities:

 
Proceeds from (Repayment of) Revolving Credit Facility, net 

 

24,511

 

 

(6,632

)

Repayments of Term Loan 

 

(1,021

)

 

(979

)

Issuance of Common Stock 

 

1,238

 

 

474

 

Repurchase of Common Stock 

 

(5,649

)

 

(1,287

)

Net Cash Provided by (Used in) Financing Activities 

 

19,079

 

 

 

(8,424

)

  

Effect of Exchange Rate Changes on Cash

 

 

90

 

 

 

(473

)

  

Net Increase in Cash

 

 

1,991

 

 

463

 

Cash at Beginning of Period

 

 

560

 

 

 

499

 

Cash at End of Period

 

$

2,551

 

 

$

962

 

TRANSCAT, INC.

Adjusted EBITDA Reconciliation Table

(in thousands)

(Unaudited)

 
 

Fiscal 2022

      
 

Q1

 

Q2

 

Q3

 

Q4

 

YTD

Net Income

 

$

3,688

 

 

$

3,015

 

   

$

6,703

 

+ Interest Expense 

 

189

 

 

 

169

 

   

 

358

 

+ Other Expense / (Income) 

 

6

 

 

 

81

 

   

 

87

 

+ Tax Provision 

 

(194

)

 

 

313

 

 

 

 

 

 

 

119

 

Operating Income

 

$

3,689

 

 

$

3,578

 

 

 

 

 

 

$

7,267

 

+ Depreciation & Amortization 

 

1,990

 

 

 

2,141

 

 

 

 

 

 

 

4,131

 

+ Transaction Expense

 

 

-

 

 

 

821

 

 

 

 

 

 

 

821

 

+ Other (Expense) / Income 

 

(6

)

 

 

(81

)

   

 

(87

)

+ Noncash Stock Compensation 

 

437

 

 

 

620

 

 

 

 

 

 

 

1,057

 

Adjusted EBITDA

 

$

6 110

 

 

$

7,079

 

 

 

 

 

 

$

13,189

 

      

Segment Breakdown

     
      

Service Operating Income

 

$

2,974

 

 

$

2,647

 

   

$

5,621

 

+ Depreciation & Amortization 

 

1,488

 

 

 

1,634

 

   

 

3,122

 

+ Transaction Expense

 

 

-

 

 

 

821

 

 

 

 

 

 

 

821

 

+ Other (Expense) / Income 

 

(2

)

 

 

(56

)

   

 

(58

)

+ Noncash Stock Compensation 

 

261

 

 

 

414

 

 

 

 

 

 

 

675

 

Service Adjusted EBITDA

 

$

4,721

 

 

$

5,460

 

 

 

 

 

 

$

10,181

 

      

Distribution Operating Income

 

$

715

 

 

$

931

 

   

$

1,646

 

+ Depreciation & Amortization 

 

502

 

 

 

507

 

   

 

1,009

 

+ Other (Expense) / Income 

 

(4

)

 

 

(25

)

   

 

(29

)

+ Noncash Stock Compensation 

 

176

 

 

 

206

 

 

 

 

 

 

 

382

 

Distribution Adjusted EBITDA

 

$

1,389

 

 

$

1,619

 

 

 

 

 

 

$

3,008

 

      
 

Fiscal 2021

      
 

Q1

 

Q2

 

Q3

 

Q4

 

YTD

Net Income

 

$

798

 

 

$

2,024

 

 

$

1,761

 

 

$

3,208

 

 

$

7,791

 

+ Interest Expense 

 

224

 

 

 

233

 

 

 

203

 

 

 

190

 

 

 

850

 

+ Other Expense / (Income) 

 

19

 

 

 

84

 

 

 

16

 

 

 

122

 

 

 

241

 

+ Tax Provision 

 

(77

)

 

 

737

 

 

 

539

 

 

 

992

 

 

 

2,191

 

Operating Income

 

$

964

 

 

$

3,078

 

 

$

2,519

 

 

$

4,512

 

 

$

11,073

 

+ Depreciation & Amortization 

 

1,871

 

 

 

1,864

 

 

 

1,861

 

 

 

1,984

 

 

 

7,580

 

+ Restructuring Expense

 

 

360

 

 

 

-

 

 

 

-

 

 

 

290

 

 

 

650

 

+ Other (Expense) / Income 

 

(19

)

 

 

(85

)

 

 

(15

)

 

 

(122

)

 

 

(241

)

+ Noncash Stock Compensation 

 

312

 

 

 

366

 

 

 

197

 

 

 

638

 

 

 

1,513

 

Adjusted EBITDA

 

$

3,488

 

 

$

5,223

 

 

$

4,562

 

 

$

7,302

 

 

$

20,575

 

      

Segment Breakdown

     
      

Service Operating Income

 

$

1,129

 

 

$

2,977

 

 

$

1,956

 

 

$

4,379

 

 

 

10,441

 

+ Depreciation & Amortization 

 

1,394

 

 

 

1,359

 

 

 

1,372

 

 

 

1,472

 

 

 

5,597

 

+ Restructuring Expense

 

 

193

 

 

 

-

 

 

 

-

 

 

 

156

 

 

 

349

 

+ Other (Expense) / Income 

 

(15

)

 

 

(57

)

 

 

(8

)

 

 

(82

)

 

 

(162

)

+ Noncash Stock Compensation 

 

162

 

 

 

196

 

 

 

126

 

 

 

351

 

 

 

835

 

Service Adjusted EBITDA

 

$

2,863

 

 

$

4,475

 

 

$

3,446

 

 

$

6,276

 

 

$

17,060

 

      

Distribution Operating Income

 

$

(165

)

 

$

101

 

 

$

563

 

 

$

133

 

 

$

632

 

+ Depreciation & Amortization 

 

477

 

 

 

505

 

 

 

489

 

 

 

512

 

 

 

1,983

 

+ Restructuring Expense

 

 

167

 

 

 

-

 

 

 

-

 

 

 

134

 

 

 

301

 

+ Other (Expense) / Income 

 

(4

)

 

 

(28

)

 

 

(7

)

 

 

(40

)

 

 

(79

)

+ Noncash Stock Compensation 

 

150

 

 

 

170

 

 

 

71

 

 

 

287

 

 

 

678

 

Distribution Adjusted EBITDA

 

$

625

 

 

$

748

 

 

$

1,116

 

 

$

1,026

 

 

$

3,515

 

TRANSCAT, INC.

Additional Information - Business Segment Data

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

Change

SERVICE

 

FY 2022 Q2

 

FY 2021 Q2

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Service Revenue

 

$

29,544

 

 

$

24,554

 

 

$

4,990

 

20.3

%

Cost of Service Revenue

 

 

19,832

 

 

 

16,654

 

 

 

3,178

 

19.1

%

Gross Profit

 

$

9,712

 

 

$

7,900

 

 

$

1,812

 

22.9

%

Gross Margin

 

 

32.9

%

 

 

32.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

2,835

 

 

$

2,427

 

 

$

408

 

16.8

%

General and Administrative Expenses

 

 

4,230

 

 

 

2,496

 

 

 

1,734

 

69.5

%

Operating Income

 

$

2,647

 

 

$

2,977

 

 

$

(330

)

(11.1

%)

% of Revenue

 

 

9.0

%

 

 

12.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

DISTRIBUTION

 

FY 2022 Q2

 

FY 2021 Q2

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Distribution Sales

 

$

20,843

 

 

$

17,053

 

 

$

3,790

 

22.2

%

Cost of Distribution Sales

 

 

15,944

 

 

 

13,459

 

 

 

2,485

 

18.5

%

Gross Profit

 

$

4,899

 

 

$

3,594

 

 

$

1,305

 

36.3

%

Gross Margin

 

 

23.5

%

 

 

21.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

2,139

 

 

$

1,864

 

 

$

275

 

14.8

%

General and Administrative Expenses

 

 

1,829

 

 

 

1,629

 

 

 

200

 

12.3

%

Operating Income

 

$

931

 

 

$

101

 

 

$

830

 

821.8

%

% of Sales

 

 

4.5

%

 

 

0.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

TOTAL

 

FY 2022 Q2

 

FY 2021 Q2

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Total Revenue

 

$

50,387

 

 

$

41,607

 

 

$

8,780

 

21.1

%

Total Cost of Revenue

 

 

35,776

 

 

 

30,113

 

 

 

5,663

 

18.8

%

Gross Profit

 

$

14,611

 

 

$

11,494

 

 

$

3,117

 

27.1

%

Gross Margin

 

 

29.0

%

 

 

27.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

4,974

 

 

$

4,291

 

 

$

683

 

15.9

%

General and Administrative Expenses

 

 

6,059

 

 

 

4,125

 

 

 

1,934

 

46.9

%

Operating Income

 

$

3,578

 

 

$

3,078

 

 

$

500

 

16.2

%

% of Revenue

 

 

7.1

%

 

 

7.4

%

 

 

 

 

TRANSCAT, INC.

Additional Information - Business Segment Data

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

Change

SERVICE

 

FY 2022 YTD

 

FY 2021 YTD

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Service Revenue

 

$

57,101

 

 

$

47,521

 

 

$

9,580

 

20.2

%

Cost of Service Revenue

 

 

38,637

 

 

 

33,552

 

 

 

5,085

 

15.2

%

Gross Profit

 

$

18,464

 

 

$

13,969

 

 

$

4,495

 

32.2

%

Gross Margin

 

 

32.3

%

 

 

29.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

5,550

 

 

$

4,775

 

 

$

775

 

16.2

%

General and Administrative Expenses

 

 

7,293

 

 

 

5,088

 

 

 

2,205

 

43.3

%

Operating Income

 

$

5,621

 

 

$

4,106

 

 

$

1,515

 

36.9

%

% of Revenue

 

 

9.8

%

 

 

8.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

DISTRIBUTION

 

FY 2022 YTD

 

FY 2021 YTD

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Distribution Sales

 

$

41,076

 

 

$

32,990

 

 

$

8,086

 

24.5

%

Cost of Distribution Sales

 

 

31,409

 

 

 

26,056

 

 

 

5,353

 

20.5

%

Gross Profit

 

$

9,667

 

 

$

6,934

 

 

$

2,733

 

39.4

%

Gross Margin

 

 

23.5

%

 

 

21.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

4,421

 

 

$

3,590

 

 

$

831

 

23.1

%

General and Administrative Expenses

 

 

3,600

 

 

 

3,408

 

 

 

192

 

5.6

%

Operating Income

 

$

1,646

 

 

$

(64

)

 

$

1,710

 

2671.9

%

% of Sales

 

 

4.0

%

 

 

(0.2

%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

TOTAL

 

FY 2022 YTD

 

FY 2021 YTD

 

$'s

 

%

 

 

 

 

 

 

 

 

 

Total Revenue

 

$

98,177

 

 

$

80,511

 

 

$

17,666

 

21.9

%

Total Cost of Revenue

 

 

70,046

 

 

 

59,608

 

 

 

10,438

 

17.5

%

Gross Profit

 

$

28,131

 

 

$

20,903

 

 

$

7,228

 

34.6

%

Gross Margin

 

 

28.7

%

 

 

26.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

 

$

9,971

 

 

$

8,365

 

 

$

1,606

 

19.2

%

General and Administrative Expenses

 

 

10,893

 

 

 

8,496

 

 

 

2,397

 

28.2

%

Operating Income

 

$

7,267

 

 

$

4,042

 

 

$

3,225

 

79.8

%

% of Revenue

 

 

7.4

%

 

 

5.0

%

 

 

 

 

 

View source version on businesswire.com:https://www.businesswire.com/news/home/20211102006305/en/

CONTACT: Mark A. Doheny, Chief Financial Officer

Phone: (585) 563-5766

Email:mark.doheny@transcat.com

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH OTHER ENERGY AEROSPACE UTILITIES MANUFACTURING ENERGY PHARMACEUTICAL DEFENSE OTHER SCIENCE MEDICAL DEVICES OTHER DEFENSE SCIENCE MEDICAL SUPPLIES

SOURCE: Transcat, Inc.

Copyright Business Wire 2021.

PUB: 11/02/2021 04:15 PM/DISC: 11/02/2021 04:17 PM

http://www.businesswire.com/news/home/20211102006305/en